In a murine model of PD, increased Cx43 hemichannel activity led to increased intracellular calcium in astrocytes and increased neuronal loss, and interestingly the administration of gap19, a Cx43 blocker, reverted dopaminergic neuron loss and microglia activation [155]. Here, GJA1 is linked to Parkinson disease.